In his lawsuit, Murray, now 26, alleged that he developed breasts after his doctors began prescribing him Risperdal off-label in 2003 after a psychologist diagnosed him with autism spectrum disorder.
The plaintiff, Nicholas Murray, similar to other male plaintiffs in the mass tort litigation over Risperdal, alleges that after being prescribed the medicine when he was a minor, he grew breasts, an incurable condition known as gynecomastia. That award later was cut to $680,000 under Maryland law.
The case, brought by Nicholas Murray, is one of 13,400 Risperdal-related lawsuits, according to J&J's latest SEC filings.
Last year, a Missouri jury ordered the company to pay $4.69 billion to 22 women who say Johnson & Johnson's talcum powder gave them ovarian cancer. The company already has settled some cases, he noted. By that measure, the punitive damages should be more in the neighborhood of $6 million. "It may make sense to get out now". "United States Supreme Court precedent dictates that punitive damages awards that are a double-digit multiplier of the compensatory award should be set aside", the spokesperson said. The drugmaker also faulted a judge's refusal to allow it to present mitigating evidence about Janssen's handling of the drug.
Johnson & Johnson denied the allegations, and said it's confident the ruling will be overturned.
J&J shares fell $3.11, or 2.4%, to $128.73 in premarket trading on Wednesday. The company did not admit it helped cause the epidemic.
Australia mum on doable swap of detainees with Iran
The couple were arrested in Tehran three months ago over unauthorized drone flying and were held in the Evin prison since then. Payne said King and Firkin were in good health and good spirits, and had requested privacy.
It's just the latest ruling that J&J's increasingly busy legal department must deal with - the United States giant is also facing a court battle over its role in the USA opioid crisis, plus challenges over the safety of its vaginal mesh implants, and baby powder allegedly tainted with asbestos.
The USDA had approved the drug in 1993, but the plaintiffs claim Johnson & Johnson inappropriately marketed it for unauthorized use for children.
While the drug can treat certain mental health disorders, Murray's lawyers charged that it also has a tendency to create a hormonal imbalance, with elevated levels of a hormone called prolactin.
A Pennsylvania Superior Court ruling in 2018 cleared the way for punitive damages to be considered in Risperdal cases tried in the state.
The $8 billion verdict is four times the size of the next-largest USA award so far this year. Murray sued the company in 2013 eventually being awarded $1.75 million in damages, according to a release by Murray's lawyers following the verdict in 2015.